Apolipoprotein CIII in Apolipoprotein B Lipoproteins Enhances the Adhesion of Human Monocytic Cells to Endothelial Cells-Reference-Cited by-同舟云学术

Apolipoprotein CIII in Apolipoprotein B Lipoproteins Enhances the Adhesion of Human Monocytic Cells to Endothelial Cells

Published:2006-02-07 Issue:5 Volume:113 Page:691-700
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Kawakami Akio¹,Aikawa Masanori¹,Libby Peter¹,Alcaide Pilar¹,Luscinskas Francis W.¹,Sacks Frank M.¹

Affiliation:

1. From the Department of Nutrition, Harvard School of Public Health (A.K., F.M.S.), and Cardiovascular Medicine (M.A., P.L., F.M.S.) and Center for Excellence in Vascular Biology, Department of Pathology (P.A., F.W.L.), Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.

2. Rate of Production of Plasma and Very-Low-Density Lipoprotein (VLDL) Apolipoprotein C-III Is Strongly Related to the Concentration and Level of Production of VLDL Triglyceride in Male Subjects with Different Body Weights and Levels of Insulin Sensitivity

3. [2] Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between apolipoprotein C-III levels and coronary calcification detected by intravascular ultrasound in patients who underwent percutaneous coronary intervention;Frontiers in Cardiovascular Medicine;2024-08-21

2. Inhibitors of apolipoprotein C3, triglyceride levels, and risk of pancreatitis: a systematic review and meta-analysis;Reviews in Endocrine and Metabolic Disorders;2024-07-13

3. Decades Long Involvement of THP-1 Cells as a Model for Macrophage Research: A Comprehensive Review;Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry;2024-06

4. APOA1/C3/A4/A5 Gene Cluster at 11q23.3 and Lipid Metabolism Disorders: From Epigenetic Mechanisms to Clinical Practices;Biomedicines;2024-05-31

5. Role of APOC3 3238C/G, APOB 12669G/A and SCARB1 1050C/T polymorphisms, their expression in patients of HIV-associated lipodystrophy;Heliyon;2024-05